Nissan Motor Co. postponed the release of its electric flagship model Ariya SUV due to the persisting semiconductor shortage.
The Ariya SUV was set to go on sale in mid-2021 but Nissan changed plans and said a limited edition would instead be available in Japan in winter before a domestic and global rollout.
Nissan Executive Vice President Asako Hoshino blamed the longer than expected COVID-19 and semiconductor shortages as the cause of delay.
The company decided to launch the Ariya SUV in Winter because its innovative technologies need thorough checking.
The Ariya SUV comes with tech features such as Nissan’s ProPilot 2.0 autonomous driving technology, a self-parking feature, and Amazon’s voice-based digital assistant Alexa.
The carmaker is sales of Ariya for its debut year to be in the tens of thousands and Europe likely to contribute heavily to its sales volumes.
Nissan expects the chip shortage to impact about 500,000 units of its output this fiscal year.


Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Australian Household Spending Dips in December as RBA Tightens Policy
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Gold and Silver Prices Climb in Asian Trade as Markets Eye Key U.S. Economic Data
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Anta Sports Expands Global Footprint With Strategic Puma Stake
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



